Pfam Domains GO Terms
| TNF |
| positive regulation of T cell chemotaxis |
| regulation of T cell chemotaxis |
| positive regulation of myoblast fusion |
| regulation of myoblast fusion |
| positive regulation of lymphocyte chemotaxis |
| positive regulation of myoblast differentiation |
| cysteine-type endopeptidase inhibitor activity involved in apoptotic process |
| regulation of lymphocyte chemotaxis |
| positive regulation of syncytium formation by plasma membrane fusion |
| regulation of syncytium formation by plasma membrane fusion |
| tumor necrosis factor receptor binding |
| positive regulation of T cell migration |
| positive regulation of myotube differentiation |
| T cell homeostasis |
| positive regulation of lymphocyte migration |
| T cell proliferation |
| regulation of T cell migration |
| regulation of myoblast differentiation |
| lymphocyte homeostasis |
| T cell costimulation |
| lymphocyte costimulation |
| regulation of myotube differentiation |
| positive regulation of striated muscle cell differentiation |
| regulation of lymphocyte migration |
| leukocyte homeostasis |
| positive regulation of NIK/NF-kappaB signaling |
| cellular response to mechanical stimulus |
| negative regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| lymphocyte proliferation |
| mononuclear cell proliferation |
| positive regulation of muscle cell differentiation |
| positive regulation of leukocyte chemotaxis |
| negative regulation of cysteine-type endopeptidase activity |
| leukocyte proliferation |
| regulation of striated muscle cell differentiation |
| regulation of NIK/NF-kappaB signaling |
| regulation of leukocyte chemotaxis |
| tumor necrosis factor-mediated signaling pathway |
| positive regulation of leukocyte migration |
| positive regulation of chemotaxis |
| regulation of muscle cell differentiation |
| cytokine activity |
| regulation of leukocyte migration |
| homeostasis of number of cells |
| positive regulation of T cell activation |
| response to mechanical stimulus |
| regulation of chemotaxis |
| regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| positive regulation of leukocyte cell-cell adhesion |
| T cell activation |
| cellular response to tumor necrosis factor |
| regulation of cysteine-type endopeptidase activity |
| negative regulation of endopeptidase activity |
| negative regulation of peptidase activity |
| positive regulation of cell-cell adhesion |
| response to tumor necrosis factor |
| regulation of leukocyte cell-cell adhesion |
| cellular response to abiotic stimulus |
| cellular response to environmental stimulus |
| regulation of T cell activation |
| cellular response to external stimulus |
| signaling receptor binding |
| negative regulation of proteolysis |
| positive regulation of lymphocyte activation |
| lymphocyte activation |
| regulation of cell-cell adhesion |
| positive regulation of leukocyte activation |
| positive regulation of cell adhesion |
| positive regulation of cell activation |
| regulation of endopeptidase activity |
| regulation of peptidase activity |
| negative regulation of hydrolase activity |
| positive regulation of cell migration |
| regulation of lymphocyte activation |
| positive regulation of cell motility |
| positive regulation of cellular component movement |
| positive regulation of locomotion |
| cell population proliferation |
| positive regulation of response to external stimulus |
| regulation of leukocyte activation |
| regulation of cell activation |
| cytokine-mediated signaling pathway |
| regulation of cell adhesion |
| regulation of proteolysis |
| negative regulation of catalytic activity |
| regulation of cell migration |
| negative regulation of apoptotic process |
| negative regulation of programmed cell death |
| regulation of cell motility |
| apoptotic process |
| leukocyte activation |
| positive regulation of cell differentiation |
| regulation of locomotion |
| regulation of cellular component movement |
| negative regulation of cell death |
| cellular response to cytokine stimulus |
| positive regulation of intracellular signal transduction |
| negative regulation of cellular protein metabolic process |
| programmed cell death |
| regulation of anatomical structure morphogenesis |
| cell activation |
| cell death |
| regulation of response to external stimulus |
| response to cytokine |
| negative regulation of protein metabolic process |
| negative regulation of molecular function |
| positive regulation of immune system process |
| response to abiotic stimulus |
| positive regulation of cellular component organization |
| regulation of hydrolase activity |
| positive regulation of developmental process |
| regulation of apoptotic process |
| regulation of programmed cell death |
| extracellular space |
| homeostatic process |
| positive regulation of signal transduction |
| regulation of immune system process |
| regulation of cell death |
| regulation of cell differentiation |
| positive regulation of cell communication |
| positive regulation of signaling |
| regulation of intracellular signal transduction |
| immune response |
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 0/1 |
| bile duct | 0/28 |
| blood | 1/28 |
| bone | 0/26 |
| breast | 0/33 |
| central nervous system | 0/56 |
| cervix | 0/4 |
| colorectal | 0/17 |
| esophagus | 0/13 |
| fibroblast | 0/1 |
| gastric | 0/16 |
| kidney | 0/21 |
| liver | 0/20 |
| lung | 0/75 |
| lymphocyte | 0/16 |
| ovary | 0/26 |
| pancreas | 0/24 |
| peripheral nervous system | 0/16 |
| plasma cell | 0/15 |
| prostate | 0/1 |
| skin | 0/24 |
| soft tissue | 0/9 |
| thyroid | 0/2 |
| upper aerodigestive | 0/22 |
| urinary tract | 0/29 |
| uterus | 0/5 |
Expression Distribution